Table 1.
Baseline characteristics of participants
| Demographic Data | Number (N=74) |
|---|---|
| Sex (male/female)a | 37/37 |
| Reason and setting of diagnosis | |
| Age at diagnosis, yrb | 3 (0–9) |
| Prenatal diagnosis, n (%)a | 7 (10) |
| Postnatal incidental finding, n (%)a | 14 (19) |
| Family screening, n (%)a | 49 (66) |
| Presenting features, n (%)a | 4 (5) |
| Genetic, n (%)a | |
| PKD1 | 70 (95) |
| PKD2 | 3 (4) |
| GANAB | 1 (1) |
| Anthropometric data at first measurement b | |
| Age at first 3D measurement, yr | 10 (5–14) |
| Body height, cm | 141 (114–163) |
| Weight, kg | 32 (19–52) |
| BMI, kg/m2 | 17 (15–19) |
| BMI, kg/m2, SDS (n=68) | −0.4 (−1.1 to 0.5) |
| Biochemical data at first measurement c | |
| Serum creatinine, mg/dl | 0.5±0.2 (0.2–1.4) |
| eGFR, ml/min per 1.73 m2 − CKiD | 120±33 (48–299) |
| eGFR, ml/min per 1.73 m2 − FAS-age | 112±35 (48–351) |
| Number of TKV measurements per patient, n (%) a | |
| 1 measurement | 10 (14) |
| 2 measurements | 17 (23) |
| 3 measurements | 11 (15) |
| 4 measurements | 16 (22) |
| 5 measurements | 14 (19) |
| 6 measurements | 6 (8) |
GANAB, glucosidase IIα unit; BMI, body mass index; SDS, SD score; CKiD, revised/bedside Schwartz equation; FAS, full-age spectrum; TKV, total kidney volume.
a
Values are provided as number (%).
b
Values are provided as median (interquartile range).
c
Values are provided as mean±SD (range).